Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; January 2023, Vol. 11 Issue: 1 p45-54, 10p
- Subject
- Language
- ISSN
- 22132600; 22132619